HKU Scholars Hub: Browsing DSpace

Browsing by Author Lim, Y-S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 6 of 6

	Title	Author(s)	Issue Date	Views
	AB-729, a GalNAc-siRNA, results in robust reductions of HBV DNA and HBsAg in subjects with chronic hepatitis B infection Proceeding/Conference:Hepatology International	Sevinsky, H Gane, ED Gane, E Berliba, E Kim, YJ Holmes, J Lim, Y-S Strasser, S Sukeepaisarnjaroen, W Schwabe, C Jucov, A Lee, ACH Thi, EP Harasym, T Pamulapati, GR Wattamwar, P Kunta, J Sofia, M Sevinsky, H Gray, K Eley, T Picchio, G Sims, KD Yuen, RMF	2021
	IMC-I109V, a novel T cell receptor (TCR) bispecific (ENVxCD3) designed to eliminate HBV-infected hepatocytes in chronic HBV patients: initial data from a first-in-human study. Poster Presentation (SAT437) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Bourgeois, S Lim, Y-S Gane, EJ Lee, HW Cheng, W Heo, J Kim, W Buti, M Thompson, A Matthews, G Janczewska, E Ryder, S Andrade, RJ Yuan, Y Benlahrech, A Wustner, J Dorrell, L Yuen, RMF	2022
	Preliminary results from a phase 2 study evaluating vir-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:Oral Presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Yuen, RMF Lim, Y-S Cloutier, D Thanawala, V Shen, L Arizpe, A Tay, C Gupta, SV Cathcart, AL Hwang, C Pang, PS Gane, EJ	2021
	Preliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International	Yuen, RMF Lim, Y-S Cloutier, D Thanawala, V Shen, L Arizpe, A Tay, C Gupta, SV Cathcart, AL Hwang, C Gane, E	2022
	Safety, tolerability, pharmacokinetics (PK), and antiviral activity of the capsid inhibitor (CI) AB-506 in healthy subjects (HS) and chronic hepatitis B (CHB) subjects Proceeding/Conference:Hepatology	Yuen, RMF Berliba, E Sukeepaisarnjaroen, W Ahn, SH Tanwandee, T Lim, Y-S Kim, YJ Poovorawan, K Tangkijvanich, P Chan, HLY Eley, T Brown, J Moore, C Lee, ACH Kim, J Thi, EP Mani, N Rijnbrand, R Cole, A Sofia, MJ Picchio, GR Sims, K Gane, EJ	2019	5
	Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study Journal:JHEP Reports	Ma, HY Lim, TH Leerapun, A Wellman, M Jia, JD Lim, Y-S Tangkijvanich, P Sukeepaisarnjaroen, W Ji, Y Le Bert, N Li, D Zhang, Y Hamatake, R Tan, N Li, CM Strasser, SI Ding, HG Yoon, J-H Stace, NH Ahmed, T Anderson, DE Yan, L Bertoletti, A Zhu, Q Yuen, RMF	2021

Showing results 1 to 6 of 6